- 601. Benign Osseous Neoplasm
- [A benign neoplasm arising from bone. It is characterized by the presence of neoplastic bone-forming cells and osseous differentiation. ( NCI )] (UMLS (NCI) C1332523) Benign Osseous Tumor;
Benign Osteogenic Neoplasm;
Benign Osteogenic Tumor =Neoplastic Process | - 651. Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, Chloride
- [The chloride salt form of edrophonium, a short and rapid-acting cholinesterase inhibitor with parasympathomimetic activity. Echothiophate chloride potentiates the action of endogenous acetylcholine by inhibiting acetylcholinesterase that hydrolyzes acetylcholine. When applied topically to the eye, this agent prolongs stimulation of the parasympathetic receptors at the neuromuscular junctions of the longitudinal muscle of the ciliary body. Contraction of longitudinal muscle pulls on the scleral spur, and opens the trabecular meshwork, thereby increases aqueous humor outflow from the eye and reduces intraocular pressure. ( NCI )] (UMLS (NCI) C0013617) =Organic Chemical; Pharmacologic Substance ;
=Edrophonium;
=EDROPHONIUM CHLORIDE 10 MG/ML;
|
- 602. Benign Ovarian Mixed Epithelial Neoplasm
- (UMLS (NCI) C1332525) Benign Ovarian Mixed Epithelial Tumor =Neoplastic Process
| - 652. benzene
- [toxic, volatile, flammable liquid hydrocarbon biproduct of coal distillation; structure consists of a closed hexagonal chain of six carbon atoms, each attached to a hydrogen atom and attached to each other by alternating single and double (resonating) bonds; in benzene derivatives, one or more of the hydrogen atoms are replaced by other atoms or radicals. ( CSP )] (UMLS (CSP) C0005036) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 603. Benign Ovarian Partly Luteinized Thecoma
- (UMLS (NCI) C1332526) Benign Partly Luteinized Thecoma of Ovary;
Benign Partly Luteinized Thecoma of the Ovary;
Ovarian Partly Luteinized Theca Cell Neoplasm;
Ovarian Partly Luteinized Theca Cell Tumor;
Partly Luteinized Theca Cell Neoplasm of Ovary;
Partly Luteinized Theca Cell Neoplasm of the Ovary;
Partly Luteinized Theca Cell Tumor of Ovary;
Partly Luteinized Theca Cell Tumor of the Ovary;
=Neoplastic Process | - 653. Benzene Exposure
- (UMLS (NCI) C0238760) =Finding
|
- 604. Benign Ovarian Serous Cystadenoma
- (UMLS (NCI) C0346170) =Neoplastic Process
| - 654. Benzene-Related Acute Myeloid Leukemia
- (UMLS (NCI) C1332544) =Neoplastic Process
|
- 605. Benign Ovarian Serous Neoplasm
- (UMLS (NCI) C1332527) Benign Ovarian Serous Tumor =Neoplastic Process
| - 655. Benzeneacetamide, N-ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)-
- [A synthetic muscarinic antagonist with actions similar to atropine and with an anticholinergic property. Upon ocular administration, tropicamide binds to and blocks the muscarinic receptors in the sphincter and ciliary muscle in the eye. This inhibits the responses from cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle. Tropicamide is a diagnostic agent and is used to produce short-duration mydriasis and cycloplegia. ( NCI )] (UMLS (NCI) C0041190) =Organic Chemical; Pharmacologic Substance ;
=pyridine;
[OP600] MYDRIATICS/CYCLOPLEGICS, TOPICAL OPHTHALMIC =TROPICAMIDE 0.5 %;
TROPICAMIDE 1 %;
|
- 606. Benign Ovarian Sex Cord-Stromal Neoplasm
- (UMLS (NCI) C1332528) Benign Ovarian Sex Cord-Stromal Tumor;
Benign Sex Cord-Stromal Neoplasm of Ovary;
Benign Sex Cord-Stromal Neoplasm of the Ovary;
Benign Sex Cord-Stromal Tumor of Ovary;
Benign Sex Cord-Stromal Tumor of the Ovary =Neoplastic Process | - 656. Benzeneacetic Acid, 3-benzoyl-alpha-methyl-
- [A propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic effects. Ketoprofen inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis, by prostaglandin synthase, is responsible for the therapeutic effects of ibuprofen. Ketoprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. ( NCI )] (UMLS (NCI) C0022635) =Organic Chemical; Pharmacologic Substance =Phenylpropionates;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC =KETOPROFEN 12.5 MG;
KETOPROFEN 150 MG;
KETOPROFEN 200 MG;
KETOPROFEN 25 MG;
KETOPROFEN 50 MG;
KETOPROFEN 75 MG;
KETOPROFEN 100 MG |
- 607. Benign Ovarian Thecal Cell Neoplasm
- (UMLS (NCI) C1332529) Benign Ovarian Thecal Cell Tumor;
Benign Ovarian Thecoma;
Benign Thecal Cell Neoplasm of Ovary;
Benign Thecal Cell Neoplasm of the Ovary;
Benign Thecal Cell Tumor of Ovary;
Benign Thecal Cell Tumor of the Ovary;
Benign Thecoma of Ovary;
Benign Thecoma of the Ovary;
=Neoplastic Process | - 657. Benzeneethanamine, N,alpha-dimethyl-, Hydrochloride(9CI)
- [The hydrochloride salt form of methamphetamine, an amphetamine and sympathomimetic amine with CNS stimulating properties. Methamphetamine hydrochloride acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibits their uptake. This leads to an increase in synaptic concentration of these neurotransmitters and results in an increase of motor activity, causes euphoria, mental alertness and excitement and suppresses appetite. Methamphetamine hydrochloride causes dependence and may cause an increase in heart rate and blood pressure. ( NCI )] (UMLS (NCI) C0282233) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance =Methamphetamine;
=METHAMPHETAMINE HYDROCHLORIDE 1 MG;
METHAMPHETAMINE HYDROCHLORIDE 10 MG;
METHAMPHETAMINE HYDROCHLORIDE 15 MG;
METHAMPHETAMINE HYDROCHLORIDE 5 MG;
|
- 608. Benign Paraganglioma
- [A paraganglioma that is confined to the site of origin, without metastatic potential. ( NCI )] (UMLS (NCI) C0334413) =Neoplastic Process
| - 658. Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alphaS)-,Sulfate (2:1) (salt)
- [The sulfate salt form of pseudoephedrine, a phenethylamine and a diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine sulfate displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion. ( NCI )] (UMLS (NCI) C0304431) =Organic Chemical; Pharmacologic Substance =PSEUDOEPHEDRINE;
=PSEUDOEPHEDRINE SULFATE 120 MG;
PSEUDOEPHEDRINE SULFATE 60 MG;
PSEUDOEPHEDRINE SULFATE 20 MG;
PSEUDOEPHEDRINE SULFATE 240 MG;
|
- 609. Benign paroxysmal positional vertigo
- (UMLS (ICD9CM) C0155502) =Disease or Syndrome ;
| - 659. benzenesulfonamide
- [ ] (UMLS (CSP) C0053169) =Organic Chemical; Pharmacologic Substance ;
=sulfonamide;
=bumetanide;
FRS;
4-Aminobenzenesulfonamide |
- 610. Benign Pericardial Teratoma
- (UMLS (NCI) C1334638) Mature Pericardial Teratoma;
Mature Teratoma of Pericardium;
Mature Teratoma of the Pericardium =Neoplastic Process ;
| - 660. Benzenesulfonamide, 2-chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)-
- [A thiazide diuretic of the sulfamoylbenzamide class. Chlorthalidone directly inhibits sodium and chloride reabsorption on the luminal membrane of the early segment in the distal convoluted tubule in the kidney. This leads to an increase in water, sodium, chloride, bicarbonate, and potassium secretion and a decrease in calcium and uric acid secretion. Chlorthalidone is used in the treatment of high blood pressure, edema and congestive heart failure. ( NCI )] (UMLS (NCI) C0008294) =Organic Chemical; Pharmacologic Substance ;
=[CV701] THIAZIDES/RELATED DIURETICS;
sulfonamide =CHLORTHALIDONE 100 MG;
CHLORTHALIDONE 15 MG;
CHLORTHALIDONE 25 MG;
CHLORTHALIDONE 50 MG;
|
- 611. Benign Pericytic Neoplasm
- [A benign mesenchymal neoplasm arising from the perivascular cells of the connective and soft tissues. It is characterized by the presence of pericytes that grow in a circumferential pattern around vessels. ( NCI )] (UMLS (NCI) C1332532) Benign Pericytic Tumor;
Benign Perivascular Neoplasm;
Benign Perivascular Tumor =Neoplastic Process | - 661. Benzenesulfonamide, 4-amino-N-(5,6-dimethoxy-4-pyrimidinyl)-
- [A broad-spectrum sulfanilamide and a synthetic analog of para-aminobenzoic acid (PABA) with bacteriostatic and antimalarial properties. Sulfadoxine competes with PABA for the bacterial enzyme dihydropteroate synthase, thereby preventing the incorporation of PABA into dihydrofolic acid, the immediate precursor of folic acid. This leads to an inhibition of parasitic folic acid synthesis and de novo synthesis of purines and pyrimidines, ultimately resulting in cell growth arrest and cell death. ( NCI )] (UMLS (NCI) C0038679) =Organic Chemical; Pharmacologic Substance =Sulfanilamides;
[AM650] SULFONAMIDE/RELATED ANTIMICROBIALS =SULFADOXINE 500 MG;
|
- 612. Benign Peritoneal Mesothelioma
- (UMLS (NCI) C0346113) =Neoplastic Process
| - 662. Benzenesulfonamide, 4-amino-N-(5-chloro-2-quinoxalinyl)-
- [Chloroquinoxaline sulfonamide. A substance that is being studied as an anticancer drug. ( NCI )] (UMLS (NCI) C0049111) =Organic Chemical; Pharmacologic Substance ;
|
- 613. Benign Peritoneal Neoplasm
- (UMLS (NCI) C0854185) =Neoplastic Process
| - 663. Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-
- [sulfonamide bacteriostatic antibacterial agent. ( CSP )] (UMLS (NCI) C0038689) =Organic Chemical; Pharmacologic Substance =4-Aminobenzenesulfonamide;
Sulfanilamides;
[AM650] SULFONAMIDE/RELATED ANTIMICROBIALS;
=Sulfamethoxazole 100 MG/ML;
SULFAMETHOXAZOLE 1 GM;
SULFAMETHOXAZOLE 200 MG/5ML;
SULFAMETHOXAZOLE 400 MG;
SULFAMETHOXAZOLE 500 MG;
SULFAMETHOXAZOLE 80 MG/ML;
SULFAMETHOXAZOLE 800 MG;
|
- 614. Benign Phyllodes Neoplasm of Prostate
- (UMLS (NCI) C1332535) Benign Phyllodes Neoplasm of the Prostate;
Benign Phyllodes Tumor of Prostate;
Benign Phyllodes Tumor of the Prostate;
Benign Prostate Phyllodes Neoplasm;
Benign Prostate Phyllodes Tumor =Neoplastic Process | - 664. Benzenesulfonamide, 4-chloro-N-((propylamino)carbonyl)-
- [A sulfonylurea with oral hypoglycemic properties that is used in the treatment of Type II diabetes mellitus. Chlorpropamide stimulates pancreatic secretion of insulin and improves insulin release by increasing sensitivity of beta cells to glucose stimuli. This drug also increases the sensitivity of insulin receptors in muscle, liver, and adipose tissue thereby promoting glucose transport across cell membranes. This results in better controlled blood glucose levels. Chlorpropamide has the longest duration of action of the sulfonylurea class but could cause more severe and frequent side effects, including hypoglycemia and hyponatremia. ( NCI )] (UMLS (NCI) C0008287) =Organic Chemical; Pharmacologic Substance ;
=sulfonylurea;
[HS502] HYPOGLYCEMIC AGENTS, ORAL =CHLORPROPAMIDE 100 MG;
CHLORPROPAMIDE 250 MG;
|
- 615. Benign Pilomatricoma
- [A benign adnexal neoplasm arising from hair-bearing skin surfaces, usually the head and neck and upper extremities. It usually presents as a solitary, slow-growing nodular mass. Morphologically, it displays differentiation towards the matrix and inner sheath of the normal hair follicle and the hair cortex. Complete surgical excision is usually curative. Occasionally, it may recur. ( NCI )] (UMLS (NCI) C0206711) =Neoplastic Process =Basal Cell Neoplasm;
| - 665. Benzethyzin
- [antineoplastic agent specific for the S phase of the cell cycle, used in combination with mechlorethamine, vincristine, and prednisone (MOPP protocol) in the treatment of Hodgkin's disease, and in treatment of other neoplasms. ( CSP )] (UMLS (NCI) C0033223) =Organic Chemical; Pharmacologic Substance =[AN000] ANTINEOPLASTICS;
Benzamides;
hydrazine;
=Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI) |
- 616. benign proliferative breast disease
- [A group of noncancerous conditions that may increase the risk of developing breast cancer. Examples include ductal hyperplasia, lobular hyperplasia, and papillomas. ( NCI )] (UMLS (NCI) C1332629) Breast Fibrocystic Change, Proliferative Type;
Proliferative Breast Disease;
Proliferative Breast Lesion;
Proliferative Fibrocystic Change;
Proliferative Type Fibrocystic Change of Breast;
Proliferative Type Fibrocystic Change of the Breast;
=Disease or Syndrome ;
| - 666. benzilate
- [ ] (UMLS (CSP) C0005049) =Organic Chemical ;
|
- 617. Benign prostatic hypertrophy
- [(hye-per-PLAY-zha) A benign (noncancerous) condition in which an overgrowth of prostate tissue pushes against the urethra and the bladder, blocking the flow of urine.(NCI)] (UMLS (ICPC) C0005001) (Benign prostatic hypertrophy; (194); Prostatahypertrofi; Benigne prostaat hypertrofie; HYVANLAATUINEN ETURAUHASEN SUURENTUMINEN; Adenome de la prostate; Prostatahyperplasie; hagdala tava shel haarmonit; benignus prostata hypertrophia; Ipertrofia prostatica benigna; GODARTET PROSTATA-HYPERTROFI; Hipertrofia prostatica benigna; Hipertrofia benigna de prostata; GODARTAD PROSTATAHYPERPLASI) =Pathologic Function ;
| - 667. benzimidazole
- [Compounds with a BENZENE fused to IMIDAZOLES. ( MSH )] (UMLS (CSP) C0005050) =Organic Chemical ;
|
- 618. BENIGN RENOVASC HYPERTEN
- [ ] (UMLS (ICD9CM) C0155621) =Disease or Syndrome
| - 668. benzimidazole analog
- [synthetic or natural chemical compounds which resemble benzimidazole in structure and/or function. ( CSP )] (UMLS (CSP) C0178501) =Organic Chemical ;
=analog;
|
- 619. Benign Reproductive System Neoplasm
- (UMLS (NCI) C1332536) =Neoplastic Process
| - 669. benznidazole/CCNU
- (UMLS (NCI) C0281615) =Therapeutic or Preventive Procedure
|
- 620. Benign respiratory neoplasm
- (UMLS (ICPC) C0497556) (Benign respiratory neoplasm; TUMORE ONAIREA; Godartet svulst; Benigne neoplasma; HYVANLAATUINEN KASVAIN; Tumeur benigne; gutartige Neubildung; (108); benignus tumor; Neoplasie benigne; GODARTEDE SVULSTER; Neoplasia benigna; Neoplasias benignas; BENIGNA TUMORER) Benign neoplasm; =Neoplastic Process ;
=Diagnosis/Diseases Component; Respiratory | - 670. benzo(1,2-b:4,3-b')dipyrrol-4-ol,6,6'-(carbonylbis(imino-1H-indole-5,2-diylcarbonyl))bis(8-(chloromethyl)-3,6,7,8-tetrahydro-1-methyl-,(S-(R*,R*))
- [An anticancer drug that belongs to the family of drugs called alkylating agents. It is also an antitumor antibiotic. ( NCI )] (UMLS (NCI) C0209891) =Organic Chemical; Pharmacologic Substance ;
|
- 621. Benign Retroperitoneal Neoplasm
- (UMLS (NCI) C0496873) =Neoplastic Process
| - 671. Benzo(1,2-b:4,3-b')dipyrrole-1-carboxylic Acid, 8-(bromomethyl)-3,6,7,8-tetrahydro-2-methy-4-(((4-methyl-1-piperazinyl)carbonyl)oxy)-6-((5,6,7,-trimethoxy-1H-indol-2-yl)carbonyl)-, Methyl Ester (S)
- [A semisynthetic anticancer drug that belongs to the family of drugs called antitumor antibiotics. ( NCI )] (UMLS (NCI) C0254093) =Organic Chemical; Antibiotic ;
|
- 622. BENIGN SECOND HYPERT NEC
- [ ] (UMLS (ICD9CM) C0155622) =Disease or Syndrome
| - 672. Benzo(a)pyrene-7,8-diol 9,10-Epoxide
- [A benzopyrene derivative with carcinogenic and mutagenic activity. (MeSH) ( NCI )] (UMLS (NCI) C0000641) =Organic Chemical; Hazardous or Poisonous Substance
|
- 623. Benign secondary hypertension
- [ ] (UMLS (ICD9CM) C0155620) =Disease or Syndrome
| - 673. benzoate
- [benzoic acid (C6H5COOH), and its salts, esters and derivatives; many possess antibacterial and antifungal properties and are used as preservatives in pharmaceuticals, cosmetics, and foods. ( CSP )] (UMLS (CSP) C0005058) =Organic Chemical ;
|
- 624. Benign Sertoli Cell Neoplasm of Testis
- (UMLS (NCI) C1332540) Benign Sertoli Cell Neoplasm of the Testis;
Benign Sertoli Cell Tumor of Testis;
Benign Sertoli Cell Tumor of the Testis;
Benign Testicular Sertoli Cell Neoplasm;
Benign Testicular Sertoli Cell Tumor =Neoplastic Process | - 674. Benzodepa
- [An aziridine alkylating agent that cross-links with DNA, causing inhibition of DNA synthesis. (NCI) ( NCI )] (UMLS (NCI) C0608440) =Organic Chemical ;
|
- 625. Benign shuddering attacks
- [ ] (UMLS (ICD9CM) C0375200) =Disease or Syndrome
| - 675. benzodiazepine
- [bicyclic structure consisting of fused benzene and diazepine rings; many compounds with this structure have psychotropic and neurotropic properties, and are used as sedatives, anticonvulsants, muscle relaxants, and in related applications. ( CSP )] (UMLS (CSP) C0005064) =Organic Chemical; Pharmacologic Substance
|
- 626. Benign Soft Tissue Neoplasm of Uncertain Differentiation
- [A benign soft tissue neoplasm in which the line of differentiation is uncertain. ( NCI )] (UMLS (NCI) C1332517) Benign Soft Tissue Tumor of Uncertain Differentiation =Neoplastic Process
| - 676. benzodiazepine receptor
- [family of transmembrane chloride channels which mediate effects of benzodiazepine tranquilizers in neurons, lymphocytes, and other cell types; may or may not coincide with GABA receptors. ( CSP )] (UMLS (CSP) C0205923) =Amino Acid, Peptide, or Protein; Receptor =drug receptor;
chloride channel |
- 627. benign state
- [ ] (UMLS (CSP) C0599850) =Finding
| - 677. benzodiazine
- [ ] (UMLS (CSP) C0596162) =Organic Chemical ;
|
- 628. Benign Stromal Tumor
- (UMLS (NCI) C0474833) =Neoplastic Process
| - 678. benzofuran
- [ ] (UMLS (CSP) C0005068) =Organic Chemical ;
|
- 629. Benign Supratentorial Neoplasm
- [Primary neoplasms of the brain which occur above the cerebellar tentorium. These tumors are noninvasive and tend to grow slowly. In children, craniopharyngiomas are relatively common. Fairly frequent adult supratentorial benign tumors include meningiomas and pituitary adenomas. ( NCI )] (UMLS (NCI) C0751588) Benign Supratentorial Neoplasms;
Benign Supratentorial Tumor;
Benign Supratentorial Tumors;
Supratentorial Neoplasms, Benign;
=Neoplastic Process ;
| - 679. Benzofuro(4,3,2-efg)(2)benzazocin-6-ol, 1,2,3,4,6,7,7a,11c-octahydro-9-methoxy-2-methyl-, Hydrobromide
- [The hydrobromide salt form of galantamine, a tertiary alkaloid extracted from the bulbs of daffodil. Galantamine hydrobromide competitively and reversibly inhibits acetylcholinesterase, thereby increasing the concentration and enhancing the action of acetylcholine. Galantamine hydrobromide is used in the treatment of Alzheimer's disease. The effect may lessen as the disease progresses due to fewer cholinergic neurons remaining functionally intact. (NCI05) ( NCI )] (UMLS (NCI) C0949312) Galantamine Hydrobromide;
GALANTAMINE HYDROBROMIDE PREPARATION;
Galanthamine Hydrobromide;
Lycoremine Hydrobromide =Organic Chemical; Pharmacologic Substance ;
=GALANTAMINE;
=GALANTAMINE HYDROBROMIDE 4 MG/ML;
GALANTAMINE HYDROBROMIDE 12 MG;
GALANTAMINE HYDROBROMIDE 4 MG;
GALANTAMINE HYDROBROMIDE 8 MG;
|
- 630. Benign Thymoma
- [A thymoma that is completely surrounded by a capsule, without evidence of capsular invasion, infiltration of the surrounding tissues, and metastases. ( NCI )] (UMLS (NCI) C0040101) =Neoplastic Process
| - 680. Benzoic Acid, 2-((2,6-dichloro-3-methylphenyl)amino)-, Monosodium Salt
- [The sodium salt form of meclofenamate, an anthranilic acid and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activity. Meclofenamate sodium inhibits the activity of the enzymes cyclo-oxygenase I and II, resulting in decreased formation of precursors of prostaglandins and thromboxanes. The resulting decrease in prostaglandin synthesis, by prostaglandin synthase, is responsible for the therapeutic effects of meclofenamate sodium. Meclofenamate sodium also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. ( NCI )] (UMLS (NCI) C0025041) =Organic Chemical; Pharmacologic Substance ;
=MECLOFENAMATE;
=MECLOFENAMATE SODIUM 100 MG;
MECLOFENAMATE SODIUM 50 MG;
|
- 631. Benign Tumorlet
- [A tiny localized pulmonary nodule characterized by neuroendocrine cell proliferation. It is usually discovered as an incidental finding during routine histologic examination of tissue sections or during radiologic examination. ( NCI )] (UMLS (NCI) C0334237) =Neoplastic Process
| - 681. Benzoic Acid, 2-(Acetyl-oxy)-3-[(nitrooxy)methyl]phenyl Ester
- [A nitric oxide (NO) donating derivative of aspirin, a non-steroidal anti-inflammatory drug (NSAID), with anti-inflammatory, analgesic, antipyretic, antithrombotic, gastroprotective as well as potential antitumor activities. The acetylsalicylic acid derivative inhibits the activity of cyclooxygenase I and II, thereby preventing the formation of thromboxanes and prostaglandins respectively. Reduction in prostaglandins is accountable for its anti-inflammatory, anti-pyretic and analgesic effects whereas the reduction in thromboxanes leads to an irreversible inhibition of platelet activity. Nitric oxide exerts protective activity on the gastric mucosa against the damaging effects of the aspirin derivative by modulating the protective effects of prostaglandins. In cancer cells, nitric oxide-releasing acetylsalicylic acid derivative blocks the cell cycle in the G2 phase, reduces cell proliferation and induces apoptosis through non-COX-mediated mechanisms. ( NCI )] (UMLS (NCI) C0531264) =Organic Chemical; Pharmacologic Substance
|
- 632. Benign Uvula Neoplasm
- (UMLS (NCI) C0345562) =Neoplastic Process
| - 682. Benzoic Acid, 2-Hydroxy-, 2-Carboxyphenyl Ester
- (UMLS (NCI) C0073983) =Organic Chemical; Pharmacologic Substance ;
=Salicylic Acids;
[MS101] SALICYLATES, ANTIRHEUMATIC =SALSALATE 500 MG;
SALSALATE 750 MG;
|
- 633. Benign Vascular Neoplasm
- [A benign neoplasm arising from vascular tissue usually of the skin. It is characterized by the presence of vascular channel formation and endothelial cells. ( NCI )] (UMLS (NCI) C1377916) Benign Vascular Tumor;
Vascular Neoplasms, Benign;
=Neoplastic Process | - 683. Benzoic acid, 2-hydroxy-, monosodium salt
- [A drug that belongs to the family of drugs called nonsteroidal anti-inflammatory drugs. Sodium salicylate may be tolerated by people who are sensitive to aspirin. ( NCI )] (UMLS (NCI) C0037549) =Organic Chemical; Pharmacologic Substance ;
=Salicylates;
Unclassified Ingredient Preparations =BI SUBSALICYLATE 260MG/MG AL SILICATE/SAL AC/NA SALICYLATE/30ML;
BI SUBSALICYLATE 459MG/MG AL SILICATE/SAL AC/NA SALICYLATE/30ML;
SULFUR 5% SHAMPOO;
SODIUM SALICYLATE 100 MG/ML;
SODIUM SALICYLATE 83.3 MG/5ML;
SODIUM SALICYLATE 83.33 MG;
SODIUM SALICYLATE 5 GR;
SODIUM SALICYLATE 10 GR;
|
- 634. Benign/Intermediate Mesothelioma
- (UMLS (NCI) C1337012) Well Differentiated Papillary Mesothelioma;
Well-Differentiated Mesothelial Papillary Neoplasm;
Well-Differentiated Mesothelial Papillary Tumor;
Well-Differentiated Papillary Neoplasm of Mesothelium;
Well-Differentiated Papillary Neoplasm of the Mesothelium;
Well-Differentiated Papillary Tumor of Mesothelium;
Well-Differentiated Papillary Tumor of the Mesothelium =Neoplastic Process ;
| - 684. Benzoic Acid, 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodo-, Monosodium Salt
- [The sodium salt form of ioxaglate, an organic iodine compound and a radiographic contrast medium. Ioxaglate sodium blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by ioxaglate sodium is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of ioxaglate sodium. (NCI05) ( NCI )] (UMLS (NCI) C0205808) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =IOXAGLATE;
=IOXAGLATE SODIUM 196 MG/ML;
|
- 635. Benign/unspecified neoplasms
- (UMLS (ICPC) C0497163) (Benign/unspecified neoplasms; TUMORE ONAIREA; Godartet uspec svulst; Ben/niet gespec neopl bloed/lymfest; HYVANLAATUISET KASVAIMET; Tumeurs benignes non spec; gutartige Neubild Blut/Lymphsystem; (108); joindulatu/n.m. daganatok; Neoplasie benigne/non spec; GODARTEDE SVULSTER; Neoplasia benigna NE; Neoplasias benignas/inesp; BENIGNA/OSPECIF TUMORER) =Neoplastic Process =BLOOD, BLOOD FORMING ORGANS, LYMPHATICS, SPLEEN; Diagnosis/Diseases Component
| - 685. Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, Monosodium Salt
- [The sodium salt form of iothalamate, an organic iodine compound and a radiographic contrast medium. Iothalamate sodium blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by iothalamate sodium is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of iothalamate sodium. (NCI05) ( NCI )] (UMLS (NCI) C0037523) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IOTHALAMATE;
1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate =IOTHALAMATE SODIUM 66.8 %;
IOTHALAMATE SODIUM 54.3 %;
IOTHALAMATE SODIUM 80 %;
IOTHALAMATE SODIUM 26 % |
- 636. Benin
- (UMLS (NCI) C0054258) =Organic Chemical; Pharmacologic Substance ;
| - 686. Benzoic Acid, 3-(acetylamino)diiodoiodo-(sup 125)I-5-((methylamino)carbonyl)-, Monosodium Salt
- [The sodium salt form of iothalamate, an organic iodine compound, labeled with iodine I-125 and used as a radiopharmaceutical. Iothalamate sodium I-125 is cleared by glomerular filtration without tubular secretion or reabsorption and can be used as a diagnostic tool to determine the glomerular filtration rate. ( NCI )] (UMLS (NCI) C0304984) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
|
- 637. Bennhold stain
- [Stain, Bennhold ( HL7V3.0 )] (UMLS (HL7) C1293955) Bennhold's Congo red stain;
=Laboratory Procedure =ObservationMethod;
| - 687. Benzonatate
- [A synthetic butylamino-benzoate derivative related to tetracaine and a peripherally acting antitussive, nonnarcotic Benzonatate reduces the cough reflex by anesthetizing and depressing mechanoreceptors in the respiratory passages, lungs, and pleura. It is recommended for cough relief in the common cold, bronchitis, pneumonia, and for chronic cough such as in asthma. (NCI04) ( NCI )] (UMLS (NCI) C0053229) =Organic Chemical; Pharmacologic Substance ;
=Butylamines;
[RE302] NON-OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS =BENZONATATE 100 MG;
|
- 638. Benoxinate Hydrochloride
- (UMLS (NCI) C0770372) BENOXINATE HYDROCHLORIDE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=benoxinate;
=BENOXINATE HYDROCHLORIDE 0.4 %;
| - 688. Benzoporphyrin Derivative Monoacid Ring A
- [A synthetic light-activated agent with photodynamic activity. Upon systemic administration, verteporfin accumulates in neovessels in the eye and, once stimulated by nonthermal red light in the presence of oxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to neovascular endothelium and blood vessel occlusion. (NCI04) ( NCI )] (UMLS (NCI) C0387288) =Organic Chemical; Pharmacologic Substance ;
=porphyrin;
[OP900] OPHTHALMICS, OTHER;
TO BE DELETED INGREDIENT PREPARATIONS;
=VERTEPORFIN 15 MG |
- 639. benthos
- [ ] (UMLS (CSP) C0599636) =Organism ;
| - 689. benzopyran
- [compounds with a core of fused benzo-pyran rings. ( CSP )] (UMLS (CSP) C0005078) =Organic Chemical ;
|
- 640. Bentiromide
- (UMLS (NCI) C0053122) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=4-Aminobenzoic Acid;
[DX900] DIAGNOSTICS, OTHER;
TO BE DELETED INGREDIENT PREPARATIONS;
=BENTIROMIDE 500 MG/7.5ML | - 690. benzopyrene
- [procarcinogens containing an anthracene ring with a naphthalene ring attached to it; found as a product of incomplete combustion and in coal tar. ( CSP )] (UMLS (CSP) C0005082) =Organic Chemical; Hazardous or Poisonous Substance
|
- 641. Bentyl
- (UMLS (NCI) C0700023) =Organic Chemical; Pharmacologic Substance ;
| - 691. benzopyrenediol epoxide
- [9,10-dihydroxy-11,12-epoxy-9,10,11,12- tetranhydrobenzo(a)pyrene, a metabolite of BAPN, has been called "the ultimate carcinogen"
extremely electrophilic, it can form covalent adducts with both DNA and proteins. ( CSP )] (UMLS (CSP) C0178502) =Organic Chemical; Hazardous or Poisonous Substance =benzopyrene;
Cancer Causing Agents |
- 642. BENZALDEHYDE
- [A colorless oily liquid used as a flavoring agent and to make dyes, perfumes, and pharmaceuticals. Benzaldehyde is chemically related to benzene. ( NCI )] (UMLS (NCI) C0005023) =Organic Chemical
| - 692. benzopyrrole
- [ ] (UMLS (CSP) C0596163) =Organic Chemical ;
|
- 643. benzamide
- [ ] (UMLS (CSP) C0053139) =Organic Chemical
| - 693. Benzoquinone Compound
- [benzene ring with 2 para keto groups. ( CSP )] (UMLS (NCI) C0034435) =Organic Chemical =Organic Chemical;
cyclic ketone =naphthoquinone;
2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione;
Anthracenedione;
naphthoquinone;
|
- 644. Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-
- [A synthetic benzamide with antiprotozoal activity. Nitazoxanide exerts its antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction, which is essential to anaerobic energy metabolism. PFOR enzyme reduces nitazoxanide, thereby impairing the energy metabolism. However, interference with the PFOR enzyme-dependent electron transfer reaction may not be the only pathway by which nitazoxanide exhibits antiprotozoal activity. Nitazoxanide is active against Giardia lamblia and Cryptosporidium parvum. ( NCI )] (UMLS (NCI) C0068788) =Organic Chemical; Pharmacologic Substance =[AP109] ANTIPROTOZOALS, OTHER;
Unclassified Ingredients =NITAZOXANIDE 100 MG/5ML;
| - 694. benzothiadiazine
- [Heterocyclic compounds of a ring with SULFUR and two NITROGEN atoms fused to a BENZENE ring. Members inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS and are used as DIURETICS. ( MSH )] (UMLS (CSP) C0005084) =Organic Chemical ;
|
- 645. Benzamide, 4-amino-N-(2-(diethylamino)ethyl)-, Monohydrochloride
- [The hydrochloride salt form of procainamide, an amide derivative exhibiting class 1A antiarrhythmic property and analog of procaine. Procainamide hydrochloride reversibly binds to and blocks activated (open) voltage-gated sodium channels, thereby blocks the influx of sodium ions into the cell, which leads to an increase in threshold for excitation and inhibit depolarization during phase 0 of the action potential. In addition, the effective refractory period (ERP), action potential duration (APD), and ERP/APD ratios are increased, resulting in decreased impulse conduction velocity. The lasting action potential may also be due to blockage of outward K+ currents. The result is a decrease in automaticity, increase in refractory period and slowing of impulse conduction. ( NCI )] (UMLS (NCI) C0600311) =Organic Chemical; Pharmacologic Substance ;
=PROCAINAMIDE;
=PROCAINAMIDE HYDROCHLORIDE 250 MG;
PROCAINAMIDE HYDROCHLORIDE 375 MG;
PROCAINAMIDE HYDROCHLORIDE 500 MG;
PROCAINAMIDE HYDROCHLORIDE 100 MG/ML;
PROCAINAMIDE HYDROCHLORIDE 750 MG;
PROCAINAMIDE HYDROCHLORIDE 1000 MG;
PROCAINAMIDE HYDROCHLORIDE 500 MG/ML | - 695. Benzotrichloride
- [An oily, unstable, colorless, chlorinated hydrocarbon with a penetrating odor. Benzotrichloride is used extensively as a chemical intermediate in industry for the preparation of dyes. Its derivatives are used as UV stabilizers in plastic and to manufacture antiseptics and antimicrobial agents. In the presence of moisture, its hydrolyzed vapors (benzoic acid and hydrochloric acid) are highly irritating to the skin and mucous membranes in humans. Benzotrichloride is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0053251) =Organic Chemical
|
- 646. Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI)
- [The hydrochloride salt of a methylhydrazine derivative with antineoplastic and mutagenic activities. Although the exact mode of cytotoxicity has not been elucidated, procarbazine, after metabolic activation, appears to inhibit the trans-methylation of methionine into transfer RNA (t-RNA), thereby preventing protein synthesis and consequently DNA and RNA synthesis. This agent may also undergo auto-oxidation, resulting in the formation of cytotoxic free radicals which damage DNA through an alkylation reaction. ( NCI )] (UMLS (NCI) C0205909) =Organic Chemical; Pharmacologic Substance =Benzethyzin;
=PROCARBAZINE HYDROCHLORIDE 50 MG;
| - 696. benzoxazine
- [OXAZINES with a fused BENZENE ring. ( MSH )] (UMLS (CSP) C0598594) =Organic Chemical
|
- 647. Benzamine Blue
- [An acid azo dye commonly used as a stain to distinguish viable from non-viable cells. It turns dead cells blue and viable cells unstained. It is a known animal carcinogen and an experimental teratogen. ( NCI )] (UMLS (NCI) C0041213) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Antiprotozoal Agent;
diazo compound | - 697. BENZOYL PEROXIDE
- [A peroxide with antibacterial, irritant, keratolytic, comedolytic, and anti-inflammatory activity. Upon topical application, benzoyl peroxide decomposes to release oxygen which is lethal to the bacteria Proprionibacterium acnes. Due to its irritant effect, benzoyl peroxide increases turnover rate of epithelial cells, thereby peeling the skin and promoting the resolution of comedones. Benzoyl peroxide is used in the treatment of acne vulgaris. ( NCI )] (UMLS (NCI) C0005088) =Organic Chemical; Pharmacologic Substance
|
- 648. benzanthracene
- [group of hydrocarbons in which a benzene and anthracene ring have a double bond in common. ( CSP )] (UMLS (CSP) C0005032) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 698. benzoylcholinesterase
- [An aspect of cholinesterases. ( MSH )] (UMLS (CSP) C0033791) =Amino Acid, Peptide, or Protein; Enzyme
|
- 649. benzazepine
- [bicyclic structure consisting of fused benzene and azepine rings; many compounds with this structure react with biogenicamine receptors, and so are psychotropic and neurotropic. ( CSP )] (UMLS (CSP) C0005034) =Organic Chemical
| - 699. Benzoylphenylurea
- [BPU. A substance that is being studied as an anticancer drug. It belongs to the family of drugs called antitubulin agents. ( NCI )] (UMLS (NCI) C0935907) BPU;
=Organic Chemical; Pharmacologic Substance ;
|
- 650. Benzedrine
- (UMLS (NCI) C0237408) =Organic Chemical; Pharmacologic Substance
| - 700. Benzo[a]pyrene trans-7,8-Dihydrodiol
- [A polycyclic aromatic hydrocarbon and metabolite of benzo(a)pyrene with potent cytotoxic and mutagenic properties. Benzo(a)pyrene-trans-7,8-dihydrodiol is an intermediate in the conversion of benzo(a)pyrene to the highly potent mutagen and carcinogen benzopyrene diol epoxide via cytochrome P450 CYP1A1. ( NCI )] (UMLS (NCI) C0146403) =Organic Chemical; Hazardous or Poisonous Substance ;
|
home
